Recurrent HCC tumor cells interact with cDC2/LAMP3+ DCs via CD274/CD80 and CTLA4/CD80, leading to the formation of clusters around DCs and subsequently reducing antigen presentation and T cell activation efficiency [38]. This evidence concerns the gene CD80 and neoplasm.